Medtech Atomo Diagnostics hit the ASX and its share price doubled
Medtech Atomo Diagnostics had an unusual start to life as a listed company today, holding a virtual bell-ringing as it became the first company to list on the ASX since January. But coronavirus concerns proved to be boon for the rapid blood test startup, which in the past month has turned its attention producing… Read more »